Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Helix Biopharma Corp (TSX: HBP )

0.2100 UNCHANGED
Streaming Delayed Price Updated: 3:47 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Helix Biopharma Corp

Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.
VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp. ("Helix" or the... 
From Jerzy Wilczewski
Via AccessWire
Helix Biopharma Corp. Closes Private Placement
RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of... 
From Helix BioPharma Corp.
Via AccessWire
Helix Biopharma Corp. Announces Fiscal 2022 First Quarter Results
RICHMOND HILL, ON / ACCESSWIRE / December 15, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field... 
From Helix BioPharma Corp.
Via AccessWire
Helix BioPharma Corp. Extends Period to Exercise Warrants
RICHMOND HILL, ON / ACCESSWIRE / December 14, 2021 / Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the... 
From Helix BioPharma Corp.
Via AccessWire
Helix BioPharma Corp. Provides Third Bi-Weekly MCTO Status Update
RICHMOND HILL, ON / ACCESSWIRE / November 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Provides Second Bi-Weekly MCTO Status Update
RICHMOND HILL, ON / ACCESSWIRE / November 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Provides Bi-Weekly MCTO Status Update
RICHMOND HILL, ON / ACCESSWIRE / November 1, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Delay of Annual Filings
RICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Appointment of Interim Chief Executive Officer
RICHMOND HILL, ON / ACCESSWIRE / September 20, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Appointment of New Director
RICHMOND HILL, ON / ACCESSWIRE / August 19, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management
RICHMOND HILL, ON / ACCESSWIRE / June 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Appointment of New Auditor and Extends Period to Exercise Warrants
RICHMOND HILL, ON / ACCESSWIRE / June 24, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
RICHMOND HILL, ON / ACCESSWIRE / June 14, 2021 / Helix BioPharma Corp. (TSX:HBP), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its... 
From Helix BioPharma Corp.
Via AccessWire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Product Safety Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.